5-Bromo-2-chloropyridine

Introduction

CAS No. :	53939-30-3	MDL No. :	MFCD01318951
Formula :	C5H3BrClN	Boiling Point :	-
Linear Structure Formula :	C5H3N(Br)(Cl)	InChI Key :	PEAOEIWYQVXZMB-UHFFFAOYSA-N
M.W :	192.44	Pubchem ID :	2734414
Synonyms :	2-Chloro-5-bromopyridine

Physicochemical Properties

Num. heavy atoms :	8
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.0
Num. rotatable bonds :	0
Num. H-bond acceptors :	1.0
Num. H-bond donors :	0.0
Molar Refractivity :	36.95
TPSA :	12.89 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-5.73 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.91
Log Po/w (XLOGP3) :	2.46
Log Po/w (WLOGP) :	2.5
Log Po/w (MLOGP) :	1.85
Log Po/w (SILICOS-IT) :	2.76
Consensus Log Po/w :	2.3

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	2.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.14
Solubility :	0.14 mg/ml ; 0.000728 mol/l
Class :	Soluble
Log S (Ali) :	-2.37
Solubility :	0.812 mg/ml ; 0.00422 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-3.5
Solubility :	0.0614 mg/ml ; 0.000319 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	1.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.6

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine